Vidya Sabale

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Early Breast Cancer

Estrogen Receptor

Top Venues

Pharmaceutical nanotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Md Ali Mujtaba, Mohammed Kaleem, Ragini Chaware, Ashwini Ingole, Yahya I Asiri, Mohd Zaheen Hassan, Vidya Sabale, Prafulla Sabale, Md Khalid Anwer, Danish Mahmood, Mohammed F Aldawsari
Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and In Vivo Assessment. ACS omega 9 (14) (2024)
Prafulla Sabale, Nusrat Sayyad, Abuzer Ali, Vidya Sabale, Mohammed Kaleem, Turky Omar Asar, Amena Ali, Md Ali Mujtaba, M D Khalid Anwer
Design, synthesis, molecular docking and in vitro anticancer activities of 1-(4-(benzamido)phenyl)-3-arylurea derivatives. RSC advances 14 (33) (2024)
Vidya Sabale, Vaishnavi Belokar, Manasi Jiwankar, Prafulla Sabale
Nanostructured Lipid Carrier-loaded In situ Gel for Ophthalmic Drug Delivery: Preparation and In vitro Characterization Studies. Pharmaceutical nanotechnology (2024)
Md Ali Mujtaba, Mohammed Kaleem, Ragini Chaware, Ashwini Ingole, Yahya I Asiri, Mohd Zaheen Hassan, Vidya Sabale, Prafulla Sabale, Md Khalid Anwer, Danish Mahmood, Mohammed F Aldawsari
Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and In Vivo Assessment. ACS omega 9 (14) (2024)
Md Ali Mujtaba, Mohammed Kaleem, Ragini Chaware, Ashwini Ingole, Yahya I Asiri, Mohd Zaheen Hassan, Vidya Sabale, Prafulla Sabale, Md Khalid Anwer, Danish Mahmood, Mohammed F Aldawsari
Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and In Vivo Assessment. ACS omega 9 (14) (2024)
Prafulla Sabale, Nusrat Sayyad, Abuzer Ali, Vidya Sabale, Mohammed Kaleem, Turky Omar Asar, Amena Ali, Md Ali Mujtaba, M D Khalid Anwer
Design, synthesis, molecular docking and in vitro anticancer activities of 1-(4-(benzamido)phenyl)-3-arylurea derivatives. RSC advances 14 (33) (2024)
Suchita Waghmare, Rohini Palekar, Lata Potey, Pramod Khedekar, Prafulla Sabale, Vidya Sabale
Solid Lipid Nanoparticles as an Innovative Lipidic Drug Delivery System. Pharmaceutical nanotechnology (2024)